StockNews.com Begins Coverage on Syros Pharmaceuticals (NASDAQ:SYRS)

StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a research report report published on Thursday. The firm issued a hold rating on the stock. Several other research firms have also weighed in on SYRS. JMP Securities reduced their price objective on shares of Syros Pharmaceuticals from $16.00 to $15.00 in […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Nathanaels Gray ,Richarda Young ,Jamese Bradner , ,News Ratings For Syros Pharmaceuticals Daily ,Syros Pharmaceuticals Inc ,Renaissance Technologies ,Syros Pharmaceuticals Stock Performance ,Millennium Management ,Syros Pharmaceuticals Company Profile ,Syros Pharmaceuticals ,Mirabella Financial Services ,Get Rating ,Moderate Buy ,Point Capital Management ,Syros Pharmaceuticals Daily ,Nasdaq Syrs ,Syrs ,Medical ,Initiated Coverage ,Stocknews Com ,